CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer-Reference-Cited by-同舟云学术

CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer

Published:2022-06-28 Issue:2 Volume:24 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Tang Shasha¹,Zhang Yi²,Lin Xiaoyan²,Wang Hui³,Yong Liyun²,Zhang Hongyi²,Cai Fengfeng²

Affiliation:

1. Department of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, P.R. China

2. Department of Breast Surgery, Yangpu Hospital, School of Medicine, Tongji University, Shanghai 200090, P.R. China

3. Laboratory of Tumor Molecular Biology, School of Basic Medical Sciences, Shanghai University of Medicine and Health Sciences, Shanghai 201318, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated BEAN1 expression correlates with poor prognosis, immune evasion, and chemotherapy resistance in rectal adenocarcinoma;Discover Oncology;2024-09-14

2. The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment;Expert Opinion on Therapeutic Targets;2024-07-02

3. Exploring the astonishing beneficial effects of round gourd (Praecitrullus fistulosus) and plant lectins towards cancer: A comprehensive review;International Journal of Biological Macromolecules;2024-06

4. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme;BMC Cancer;2024-01-02

5. Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?—A Way to Trick the Host’s Immune System;International Journal of Molecular Sciences;2023-12-03